Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction.

YipHan ChinJieyu LimGwyneth KongCheng Han NgRachel GohMark Dhinesh MuthiahAnurag MehtaBryan ChongChaoxing LinKai En ChanWilliam KongKian Keong PohRoger FooPing ChaiTiong-Cheng YeoAdrian F LowChi Hang LeeHuay Cheem TanMark Yan-Yee Channull RichardsPoay-Huan LohNicholas W S Chew

Published in: Diabetes, obesity & metabolism (2022)

Hepatic steatosis and advanced fibrosis have a substantial prevalence among patients with AMI. Both are associated with mortality, with an incrementally higher risk when advanced fibrosis ensues. Hepatic steatosis and fibrosis could help risk stratification of AMI patients beyond conventional risk factors.

Keyphrases

acute myocardial infarction
risk factors
cardiovascular events
end stage renal disease
percutaneous coronary intervention
newly diagnosed
ejection fraction
liver fibrosis
prognostic factors